← back to search

J. Komen

Utrecht University · NL
Area of research
Cardiology and Cardiovascular Medicine · Aquatic Science
Research interest
Research focused on Atrial fibrillation and Vitamin K antagonist, with related work in Persistence (discontinuity), Dabigatran, Valproic Acid. Notable publications include 'Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non–Vitamin K Antagonist Oral Anticoagulants', 'Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk', and 'Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study'.
h-index
citations
403
works
11
NIH funding
primary concept
email

Recent publications

Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study
European Heart Journal 2022cited by 45position: firstdoi
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
EP Europace 2021cited by 37position: firstdoi
Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
Heart 2021cited by 27position: firstdoi
Greedy caliper propensity score matching can yield variable estimates of the treatment‐outcome association—A simulation study
Pharmacoepidemiology and Drug Safety 2021cited by 20position: firstdoi
Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
European Heart Journal - Cardiovascular Pharmacotherapy 2020cited by 55position: firstdoi
Eliminated patient fee and changes in dispensing patterns of asthma medication in children—An interrupted time series analysis
Basic & Clinical Pharmacology & Toxicology 2019cited by 25position: middledoi
Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non–Vitamin K Antagonist Oral Anticoagulants
Stroke 2018cited by 77position: middledoi
Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions
Epilepsia Open 2018cited by 32position: middledoi
The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
European Journal of Clinical Pharmacology 2018cited by 23position: middledoi
Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
European Journal of Clinical Pharmacology 2017cited by 17position: firstdoi
Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis
British Journal of Clinical Pharmacology 2016cited by 45position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Paul Hjemdahl · Karolinska University Hospital7 papers (2016–2022)Tomas Forslund · Karolinska Institutet7 papers (2016–2022)Olaf H. Klungel · Utrecht University5 papers (2020–2022)Aukje K. Mantel‐Teeuwisse · Utrecht University5 papers (2018–2022)Mia von Euler · University Hospital of North Norway3 papers (2018–2018)Anton Pottegård · University of Southern Denmark3 papers (2021–2022)Jesper Hallas · Odense University Hospital3 papers (2021–2022) · 2 papers (2021–2021)Morten Olesen · Rigshospitalet2 papers (2021–2022)Morten Andersen · University of Copenhagen2 papers (2016–2018) · 2 papers (2021–2022) · 2 papers (2021–2022)Marion Bennie · University of Dundee2 papers (2021–2022) · 2 papers (2021–2022)Svetlana V. Belitser · Utrecht University1 papers (2021–2021) · 1 papers (2021–2021)I Eriksson · Ericsson (Sweden)1 papers (2018–2018)Sebastian Schneeweiß · Harvard University1 papers (2021–2021) · 1 papers (2021–2021)Ulrike Haug · University of Bremen1 papers (2021–2021)